Arcutis Biotherapeutics director Christopher Peetz files initial beneficial ownership statement
ARQT•Initial Form 3 filing
Arcutis Biotherapeutics director Christopher Peetz filed an initial Form 3 reporting 187,500 common shares held indirectly through The Peetz Family Trust.
